Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis

Post time 6 day(s) ago

journal：JAMA Dermatology

Authors：Amy S. Paller; Carsten Flohr; Michael Cork; Anthony Bewley; Andrew Blauvelt; H. Chih-ho Hong; Shinichi Imafuku; Marie L. A. Schuttelaar; Eric L. Simpson; Weily Soong; Petra Arlert; Katja Wendicke Lophaven; Azra Kurbasic; Lise Soldbro; Natacha Strange Vest; Andreas Wollenberg

Published date：2023-6-1

DOI：10.1001/jamadermatol.2023.0627

PDF link：https://jamanetwork.com/journals ... 686855555.13219.pdf

Article link：https://doi.org/10.1001/jamadermatol.2023.0627

Article Source：American Medical Association (AMA)。

Remark：

Post time 6 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[JAMA] Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[JAMA] Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis Copy